Biohaven begins first human trial of brain-penetrant drug BHV-8100
Go back to Biohaven begins first human trial of brain-penetrant drug BHV-8100| (NYSE: BHVN) | Delayed: 15.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.50 | 52 Week High | $ | |||
| Open | $15.50 | 52 Week Low | $ | |||
| Day High | $15.50 | P/E | N/A | |||
| Day Low | $15.50 | EPS | $ | |||
| Volume | 13,983 | |||||
